Price $597.04 |
Market Cap
222.47B
|
Sector Health Care |
Div. Growth
16.50%
|
|
P/E
26.3
|
P/B
6.06
|
P/S
5.84
|
Dividend %
0.20%
|
|
P/CF
191.3
|
P/FCF
29.1
|
Op. Cash Flow
10.25M
|
FCF
19.5
|
|
Op. Margin
28.00%
|
Net Margin
22.50%
|
ROE
24.90%
|
ROI
12.30%
|
|
ROA
12.90%
|
EPS Growth
133.80%
|
Current Ratio
2.1
|
Debt/Equity
55.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Holdings Inc (ASRT) | $0.90 | - | - | 48.5M | Strong Buy |
| Recro Pharma Inc (REPH) | $2.10 | - | - | 114M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.71 | - | - | 709M | Strong Buy |
| Endo International PLC (ENDP) | $2.76 | - | - | 499.7M | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $3.54 | - | - | 60.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
